🇺🇸 FDA
Patent

US 11254662

2′-halogenated-4′-thio-2′-deoxy-5-azacytidine analogs and use thereof

granted A61KA61K45/06

Quick answer

US patent 11254662 (2′-halogenated-4′-thio-2′-deoxy-5-azacytidine analogs and use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K45/06